alxoncology.com (ALXO) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan ALX Oncology Holdings (ALXO)

The development of ALX Oncology Holdings (ALXO) is constrained by stringent safety requirements and the struggle to integrate therapy into medical protocols. The cash position reflects the current 0.16 metric, which is critical for controlling the burn rate. High margins upon commercialization are secured by patents, while operating cash flow is currently supported by partnership research on solid tumors prior to the commencement of final testing stages.

ALXO - Cadangan dhuwit perusahaan ALX Oncology ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan ALX Oncology Holdings

Pambiji fundamental perusahaan:alxoncology.com ALXO
Produk merek ALX Oncology

The development of innovative evorpacept requires colossal expenditures, making the liquidity of ALX Oncology Holdings (ALXO) critically important for maintaining its scientific reputation in immunotherapy. The current funding volume 0.16 measures the capital available for operations without incurring debt, allowing for an assessment of the business's financial autonomy through changes in cash reserves.

Pesaing ALX Oncology Holdings (ALXO)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan